GLP-2 treatment reduced levels of pro-inflammatorycytokines (IFN-γ, TNF-α, and IL-1β) and induciblenitric oxide synthase, with increased levels of IL-10 in ileitis andcolitis models. Here, IL1B is linked to Crohn ileitis.